Ökaryotlarda Mikrorna'ların Nükleer İhracatında ve Kanserde XPO5’in Rolü
Özet
Ökaryotlarda mikroRNA'ların (miRNA) nükleer ihracatında ve kanser süreçlerinde Eksportin-5 (XPO5) proteininin oynadığı kritik rolü ele alan bu metin, miRNA biyogenezinin moleküler mekanizmalarını ve bu mekanizmadaki bozulmaların hastalıklara etkisini detaylandırmaktadır. miRNA’lar, gen ifadesini negatif yönde düzenleyerek hücre proliferasyonu ve apoptoz gibi temel biyolojik süreçleri kontrol ederler. Biyogenez sürecinde, çekirdekte üretilen pre-miRNA'ların sitoplazmaya taşınması XPO5 ve RanGTP kompleksi aracılığıyla gerçekleşir; bu aşama sürecin hız sınırlayıcı adımı olarak kabul edilir. XPO5'in genetik mutasyonları, epigenetik değişiklikleri veya tek nükleotid polimorfizmleri (SNP), miRNA üretimini doğrudan etkileyerek tümör ilerlemesine, metastaza ve ilaç direncine yol açabilmektedir. Özellikle meme, prostat ve kolorektal kanser gibi türlerde XPO5'in anormal ekspresyonu gözlenmiş, bu da proteinin bir onkoprotein olarak işlev görebileceğini ve potansiyel bir terapötik hedef olduğunu ortaya koymuştur. Sonuç olarak, XPO5'in yapısal özellikleri ve hastalıklarla ilişkisi, yeni nesil tanı ve tedavi stratejileri için umut verici bir biyobelirteç alanı sunmaktadır.
This text details the critical role of the Exportin-5 (XPO5) protein in the nuclear export of microRNAs (miRNAs) in eukaryotes and its impact on cancer processes. miRNAs negatively regulate gene expression, controlling fundamental biological processes such as cell proliferation and apoptosis. During biogenesis, the transport of pre-miRNAs produced in the nucleus to the cytoplasm is mediated by the XPO5 and RanGTP complex, a stage considered the rate-limiting step of the process. Genetic mutations, epigenetic modifications, or single nucleotide polymorphisms (SNPs) of XPO5 directly affect miRNA production, leading to tumor progression, metastasis, and drug resistance. Abnormal expression of XPO5 has been observed particularly in cancers such as breast, prostate, and colorectal, suggesting that the protein may function as an oncoprotein and serve as a potential therapeutic target. Consequently, the structural properties of XPO5 and its association with various diseases offer a promising area for biomarkers in next-generation diagnostic and therapeutic strategies.
Referanslar
Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993; 75: 843-54.
Vishnoi A, Rani S. MiRNA biogenesis and regulation of diseases: an overview. MicroRNA Profiling, 2017; 1-10.
Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic acids research, 2008; 36(suppl 1): D154-D158
Wu K, He J, Pu W, et al. The role of exportin-5 in microRNA biogenesis and cancer. Genomics, proteomics & bioinformatics, 2018; 16(2): 120-126.
Zhang XH, Zhang YN, Liu Z. MicroRNA in chronic rhinosinusitis and allergic rhinitis. Current allergy and asthma reports, 2014; 14(2): 415.
Di Leva G, Croce CM. miRNA profiling of cancer. Current opinion in genetics & development, 2013; 23(1): 3-11.
Calin GA, Croce CM. MicroRNA signatures in human cancers. Nature Reviews Cancer, 2006; 6(11), 857-66.
Lin D, Fu Z, Yang G, et al. Exportin-5 SUMOylation promotes hepatocellular carcinoma progression. Experimental Cell Research, 2020; 395(2): 112219.
Le Quesne J, Caldas C. Micro-RNAs and breast cancer. Moleculer Oncology. 2010; 4, 230-41.
Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America, 2004; 101: 2999–3004.
Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proceedings of the national academy of sciences, 2002; 99(24): 15524-15529.
Wing CE, Fung HYJ, Chook YM. Karyopherin-mediated nucleocytoplasmic transport. Nature Reviews Molecular Cell Biology, 2022; 23(5): 307-328.
Soyocak A. MikroRNA Polimorfizmleri ve Kanser. Tıp Fakültesi Klinikleri Dergisi, 2018; 1(1): 1-18
Hitit M, Kurar E, GÜZELOĞLU A. MikroRNA Biyogenezi. Atatürk Üniversitesi Veteriner Bilimleri Dergisi, 2015; 10(3).
Karabulut S, Bayramov KK, Gölgeli A. Belleğin Epigenetik Düzenlenmesi: Mikrorna’ların Rolü. Sağlık Bilimleri Dergisi, 2018; 27(1): 87-94.
Lin Z, Xia S, Liang Y, et al. LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription. Theranostics, 2020; 10(19), 8834.
Bartel DP, 2004. MicroRNAs: genomics, biogenesis, mechanism, and f unction. Cell, 116(2): 281-97.
Tunçer, F. Mevsimsel ve Perennial Allerjik Rinitli ve Astımlı Hastalarda miRNA Ekspresyonunun Karşılaştırmalı Olarak İncelenmesi, Ankara Yıldırım Beyazıt Üniversitesi Sağlık Bilimleri Enstitüsü. 2019.
Ghildiyal M, Zamore PD. Small silencing RNAs: an expanding universe. Nature Reviews Genetics, 2009; 10: 94-108.
Zhang JE. microRNA: emerging biomarkers in human disease and profiling challenges. The Biochemist, 2016; 38(2): 26-29.
Dhanasingh I, Choi JM, Lee SH. Karyopherins and nuclear actin transport. Biodesign, 2015; 3: 88-97.
Armağan İ, Ulupınar E. Nucleocytoplasmic Transport Defects: Cause or Consequence in Neurodegeneration and Aging?. Türk Tıp Öğrencileri Araştırma Dergisi, 2020; 2(3): 143-153.
Chook Y, Blobel G. Karyopherins and nuclear import. Current opinion in structural biology, 2001; 11(6): 703-715.
Pemberton LF, Paschal BM. Mechanisms of receptor‐mediated nuclear import and nuclear export. Traffic, 2005: 6(3): 187-198.
Uddin MH, Zonder JA, Azmi AS. Exportin 1 inhibition as antiviral therapy. Drug discovery today, 2020; 25(10), 1775-1781
Calado A, Treichel N, Müller EC, et al. Exportin‐5‐mediated nuclear export of eukaryotic elongation factor 1A and tRNA. The EMBO journal, 2002: 21(22): 6216-6224.
Brownawell AM, Macara IG. Exportin-5, a novel karyopherin, mediates nuclear export of double-stranded RNA binding proteins. The Journal of cell biology, 2002; 156(1): 53-64.
Yi R, Qin Y, Macara IG, et al. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev, 2003; 17: 3011–3016.
Shao Y, Shen Y, Zhao L, et al. Association of microRNA biosynthesis genes XPO5 and RAN polymorphisms with cancer susceptibility: Bayesian hierarchical meta-analysis. Journal of Cancer, 2020; 11(8): 2181.
Okada C, Yamashita E, Lee SJ, et al. A high-resolution structure of the pre-microRNA nuclear export machinery. Science, 2009; 326(5957): 1275-1279.
Wang X, Xu X, Ma Z, et al. .Dynamic mechanisms for pre-miRNA binding and export by Exportin-5, Rna, 2011; 17(8): 1511-1528.
Özdaş S, Canatar İ, Özdaş T. Effects of Knockdown of XPO5 by siRNA on the Biological Behavior of Head and Neck Cancer Cells. The Laryngoscope, 2021; 132(3): 569-577.
Leaderer D, Hoffman AE, Zheng T, et al. Genetic and epigenetic association studies suggest a role of microRNA biogenesis gene exportin-5 (XPO5) in breast tumorigenesis. International journal of molecular epidemiology and genetics, 2011; 2(1), 9.
Han Y, Liu Y, Gui Y, et al. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder. Journal of surgical oncology, 2013; 107(2): 201-205.
Chiosea S, Jelezcova E, Chandran U, et al. Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. The American journal of pathology, 2006; 169(5): 1812-1820.
Shigeyasu K, Okugawa Y, Toden S, et al. Exportin-5 functions as an oncogene and a potential therapeutic target in colorectal cancer. Clinical Cancer Research, 2017; 23(5), 1312-1322.
Chiosea S, Jelezcova E, Chandran U, et al. Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer research, 2007; 67(5): 2345-2350
Rape M. Ubiquitylation at the crossroads of development and disease. Nature reviews Molecular cell biology, 2018; 19(1): 59-70.
Li J, Pu W, Sun HL, et al. Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma. Cell Death & Differentiation, 2018; 25(9): 1612-1624.
Melo SA, Moutinho C, Ropero S, et al. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer cell, 2010; 18(4), 303-315.
Melo SA, Esteller M. Disruption of microRNA nuclear transport in human cancer. In Seminars in cancer biology, Academic Press. 2014; p. 46-51.
Kawahara Y. Human diseases caused by germline and somatic abnormalities in microRNA and microRNA‐related genes. Congenital anomalies, 2014; 54(1): 12-21.
Ali Syeda Z, Langden SSS, Munkhzul C, et al. Regulatory mechanism of microRNA expression in cancer. International journal of molecular sciences, 2020; 21(5), 1723.
Hata A, Kashima R. Dysregulation of microRNA biogenesis machinery in cancer. Critical reviews in biochemistry and molecular biology, 2016; 51(3): 121-134.
Tufa A, Taş A, Ağbektaş T, et al. Investigation of the relationship between exportin5 (XPO5) polymorphism and gastric cancer. Cumhuriyet Medical Journal, 2021; 43(3).
Horikawa Y, Wood CG, Yang H, et al. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clinical cancer research, 2008; 14(23), 7956-7962.
Patrão AS, Dias F, Teixeira AL, et al. XPO5 genetic polymorphisms in cancer risk and prognosis. Pharmacogenomics, 2018; 19(9): 799-808.
Puppin C, Durante C, Sponziello M, et al. Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation. Endocrine, 2014; 47(2), 528-536.
Sun HL, Cui R, Zhou J, et al. ERK activation globally downregulates miRNAs through phosphorylating exportin-5. Cancer cell, 2016; 30(5), 723-736.
Ding C, Li C, Wang H, et al. A miR-SNP of the XPO5 gene is associated with advanced non-small-cell lung cancer. OncoTargets and therapy, 2013; 6: 877.
Borghini A, Pulignani S, Mercuri A, et al. P772 The miRNA-SNP rs11077 of exportin-5 (XPO5) gene is associated with coronary artery disease risk and affects circulating miRNAs. European Heart Journal, 2018; 39: ehy564-P772.
Fawzy MS, Abu AlSel BT, Toraih EA. Analysis of microRNA processing machinery gene (DROSHA, DICER1, RAN, and XPO5) variants association with end‐stage renal disease. Journal of clinical laboratory analysis, 2020; 34(12): e23520.
Navarro A, Munoz C, Gaya A, et al. MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patients. PloS one, 2013; 8(5): e64716.
Fouad R., Wahdan M. Exportin-5 gene polymorphism and risk of HCC development in Hepatitis C Egyptian patients. Medical Science, 2020; 24(106), 4586-4591.
